DSGN - Design Therapeutics Inc. (DSGN) Q4 2023 Earnings Call Transcript
2024-03-19 20:44:02 ET
Design Therapeutics, Inc. (DSGN)
Q4 2023 Results Conference Call
March 19, 2024 4:30 PM ET
Company Participants
Sean Jeffries - COO
Pratik Shah - Chairman, CEO
Conference Call Participants
Joseph Schwartz - Leerink Partners
Laura Chico - Wedbush
Presentation
Operator
Good afternoon, and welcome to Design’s Conference Call. [Operator Instructions]. Please be advised that this call is being recorded at the company's request.
I would now like to turn the call over to Dr. Sean Jeffries, Chief Operating Officer of Design Therapeutics. You may begin.
Sean Jeffries
Welcome and thank you for joining us today. Earlier, we issued a press release outlining our fourth quarter and full year 2023 financial results and updates across our portfolio of GeneTAC small molecule genomic medicines. The slides that we'll be using today during today's call will be available along with the recording of this call in the investor section of our website at designtx.com. ...
Design Therapeutics, Inc. (DSGN) Q4 2023 Earnings Call Transcript